Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel Extension in Parkinson's Disease
NCT01634360Phase 2Terminated
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2004
- Primary completion
- Jun 2008
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 2 trial of perampanel in Parkinson's disease (PD), sponsored by Eisai Co., Ltd.. Started Nov 2004; status: terminated.
02
Drugs
perampanel
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01634360.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01634360.